University of Virginia researchers have tested an experimental glioblastoma treatment that uses focused ultrasound to help genetic molecules reach brain tumors. The approach slowed tumor growth and extended survival in animal models, according to a Nov. 1 ScienceDaily report based on material from UVA Health.

The team, led by Roger Abounader, a professor at UVA’s School of Medicine, identified microRNAs—small genetic molecules that can suppress several genes involved in the cancer’s growth. Their strategy aims to interfere with multiple cancer-driving processes rather than target just one.

Delivering those molecules is a major obstacle. The blood-brain barrier protects the brain from harmful substances but also keeps many potential cancer treatments out. The researchers used MRI guidance to direct focused ultrasound, which worked with microscopic bubbles to open that barrier temporarily. Nanoparticles carrying the microRNAs could then pass into the brain.

Glioblastoma is the most common malignant brain tumor in adults. Its cells invade nearby healthy tissue, making complete surgical removal extremely difficult. Standard care generally combines surgery with radiation and chemotherapy, but the disease remains difficult to control.

The findings, published in the Journal of Clinical Investigation, come from laboratory experiments and animal models—not patient trials. Additional research is needed before the strategy can be evaluated in people. Abounader said the team hopes to move toward future clinical trials for glioblastoma and other brain tumors.